To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Detection of Recurrence After Primary Treatment for Oropharyngeal Carcinoma
Örebro universitet, Institutionen för medicinska vetenskaper. Region Örebro län. Department of Otolaryngology, Örebro University Hospital, Örebro, Sweden.ORCID-id: 0000-0002-7871-9846
Department of Oncology, Örebro University Hospital, Örebro, Sweden.
Department of Otolaryngology, Örebro University Hospital, Örebro, Sweden; Örebro University, Örebro, Sweden.
2022 (engelsk)Inngår i: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 42, nr 11, s. 5597-5600Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND/AIM: Post-treatment surveillance of patients with squamous cell oropharyngeal carcinoma (SCOPC) consists of routine follow-up visits for 5 years. It has been suggested that this program is inefficient for finding recurrences and increasing survival. The primary study objective was to investigate how recurrences after treatment for SCOPC were detected, i.e., at routine follow-up visits, at patient-initiated visits, or incidentally. The secondary objective was to investigate whether 2-year survival after diagnosis of recurrence depended on the manner of detection.

PATIENTS AND METHODS: Patients with recurrences from SCOPC between 1988 and 2018 were included. Survival was analysed by the Kaplan-Meier method with log-rank test.

RESULTS: A total of 75 patients were included. Almost one-third were alive 2 years after the diagnosis of recurrence. Recurrences were detected at routine follow-up visits in 50.7%, at patient-initiated visits in 42.7% and 6.6% were found incidentally. There was an increased survival in the patient-initiated group, but this was not significant.

CONCLUSION: The majority of recurrences in both groups compared were amenable to curative treatment.

sted, utgiver, år, opplag, sider
International Institute of Anticancer Research, 2022. Vol. 42, nr 11, s. 5597-5600
Emneord [en]
Oropharyngeal carcinoma, recurrence detection, surveillance, survival
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-101939DOI: 10.21873/anticanres.16067ISI: 000912382600022PubMedID: 36288847Scopus ID: 2-s2.0-85140818975OAI: oai:DiVA.org:oru-101939DiVA, id: diva2:1706640
Merknad

Funding agency:

Research council at the Örebro University Hospital, Örebro, Sweden

Tilgjengelig fra: 2022-10-27 Laget: 2022-10-27 Sist oppdatert: 2026-03-09bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Landström, Fredrik

Søk i DiVA

Av forfatter/redaktør
Landström, Fredrik
Av organisasjonen
I samme tidsskrift
Anticancer Research

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 93 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf